MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 129 filers reported holding MACROGENICS INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $141,538 | -9.7% | 30,373 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $156,718 | -24.9% | 29,293 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $208,597 | +9.0% | 29,093 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $191,329 | +93.3% | 28,514 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $99,000 | +19.3% | 28,617 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $83,000 | -68.4% | 28,214 | -5.4% | 0.00% | 0.0% |
| Q1 2022 | $263,000 | -48.6% | 29,810 | -6.6% | 0.00% | -66.7% |
| Q4 2021 | $512,000 | -25.6% | 31,909 | -2.9% | 0.00% | -25.0% |
| Q3 2021 | $688,000 | -22.5% | 32,863 | -0.6% | 0.00% | +33.3% |
| Q2 2021 | $888,000 | -12.8% | 33,054 | +3.4% | 0.00% | -25.0% |
| Q1 2021 | $1,018,000 | +39.6% | 31,957 | +0.3% | 0.00% | +33.3% |
| Q4 2020 | $729,000 | -8.3% | 31,873 | +1.0% | 0.00% | -25.0% |
| Q3 2020 | $795,000 | -2.9% | 31,570 | +7.7% | 0.00% | 0.0% |
| Q2 2020 | $819,000 | +399.4% | 29,317 | +3.9% | 0.00% | +300.0% |
| Q1 2020 | $164,000 | -49.5% | 28,217 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $325,000 | -15.4% | 29,846 | -0.8% | 0.00% | -50.0% |
| Q3 2019 | $384,000 | -25.3% | 30,097 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $514,000 | +14.5% | 30,308 | +21.2% | 0.00% | 0.0% |
| Q1 2019 | $449,000 | +36.9% | 24,998 | -3.1% | 0.00% | +100.0% |
| Q4 2018 | $328,000 | -41.2% | 25,809 | -0.8% | 0.00% | -50.0% |
| Q3 2018 | $558,000 | +5.9% | 26,007 | +1.8% | 0.00% | 0.0% |
| Q2 2018 | $527,000 | -3.3% | 25,538 | +17.8% | 0.00% | 0.0% |
| Q1 2018 | $545,000 | +25.6% | 21,671 | -5.1% | 0.00% | +100.0% |
| Q4 2017 | $434,000 | +5.3% | 22,836 | +2.4% | 0.00% | 0.0% |
| Q3 2017 | $412,000 | +14.1% | 22,305 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $361,000 | -1.1% | 20,637 | +5.1% | 0.00% | 0.0% |
| Q1 2017 | $365,000 | -2.7% | 19,632 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $375,000 | -99.9% | 18,332 | -0.3% | 0.00% | -50.0% |
| Q3 2016 | $549,746,000 | +11.0% | 18,380 | +0.2% | 0.00% | 0.0% |
| Q2 2016 | $495,320,000 | +44.4% | 18,352 | +0.4% | 0.00% | +100.0% |
| Q1 2016 | $343,000,000 | -32.9% | 18,287 | +10.7% | 0.00% | -50.0% |
| Q4 2015 | $511,000,000 | +144659.2% | 16,517 | +0.1% | 0.00% | 0.0% |
| Q3 2015 | $353,000 | -99.9% | 16,499 | +0.1% | 0.00% | -33.3% |
| Q2 2015 | $625,746,000 | +58.8% | 16,480 | +31.2% | 0.00% | +50.0% |
| Q1 2015 | $394,101,000 | -10.6% | 12,563 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $440,584,000 | +61.4% | 12,563 | -3.8% | 0.00% | +100.0% |
| Q3 2014 | $272,954,000 | -3.9% | 13,060 | -0.1% | 0.00% | 0.0% |
| Q2 2014 | $283,989,000 | +161.0% | 13,069 | +234.2% | 0.00% | 0.0% |
| Q1 2014 | $108,815,000 | +4.0% | 3,910 | +2.5% | 0.00% | 0.0% |
| Q4 2013 | $104,673,000 | – | 3,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,215,675 | $6,503,861 | 2.01% |
| Bellevue Group AG | 9,609,913 | $51,413,035 | 0.73% |
| Frazier Life Sciences Management, L.P. | 1,803,204 | $9,647,141 | 0.58% |
| ARMISTICE CAPITAL, LLC | 5,600,000 | $29,960,000 | 0.43% |
| Delphia (USA) Inc. | 37,988 | $203,236 | 0.32% |
| SECTORAL ASSET MANAGEMENT INC | 352,497 | $1,885,859 | 0.31% |
| Corton Capital Inc. | 73,678 | $394,177 | 0.18% |
| Rock Springs Capital Management LP | 1,123,096 | $6,008,564 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 129,158 | $691 | 0.07% |
| PINNACLE ASSOCIATES LTD | 709,903 | $3,797,981 | 0.07% |